Deals
Mylan Chairman Said to Consider Perrigo Sweeteners to Make Deal
This article is for subscribers only.
Mylan NV’s chairman told investors he may sweeten the company’s cash-and-stock offer for Perrigo Co. by adding terms to reduce the risk to its shareholders, said people who recently met with him.
In private meetings with investors, Mylan Executive Chairman Robert Coury was adamant that Mylan won’t be bought by Teva Pharmaceutical Industries Ltd., which has made an unsolicited bid for Mylan. Teva’s offer for Mylan is contingent on Mylan dropping its bid for Perrigo.